US6136311A
(en)
|
1996-05-06 |
2000-10-24 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of cancer
|
US7208585B2
(en)
*
|
2002-09-18 |
2007-04-24 |
Genencor International, Inc. |
Protein purification
|
GB0304576D0
(en)
*
|
2003-02-28 |
2003-04-02 |
Lonza Biologics Plc |
Protein a chromatography
|
US7879800B2
(en)
|
2003-09-22 |
2011-02-01 |
Kamada Ltd. |
Large scale preparation of alpha-1 proteinase inhibitor and use thereof
|
WO2005071410A1
(en)
*
|
2004-01-13 |
2005-08-04 |
Tanox, Inc. |
Detecting and quantifying host cell proteins in recombinant protein products
|
US20050197496A1
(en)
*
|
2004-03-04 |
2005-09-08 |
Gtc Biotherapeutics, Inc. |
Methods of protein fractionation using high performance tangential flow filtration
|
US7449116B2
(en)
*
|
2004-10-01 |
2008-11-11 |
Agilent Technologies, Inc. |
Methods and systems for protein separation
|
US7943046B2
(en)
*
|
2004-10-01 |
2011-05-17 |
Agilent Technologies, Inc |
Methods and systems for on-column protein delipidation
|
US20060130159A1
(en)
*
|
2004-12-09 |
2006-06-15 |
Nick Masiello |
Method of purifying recombinant MSP 1-42 derived from Plasmodium falciparum
|
US20060182750A1
(en)
*
|
2005-02-11 |
2006-08-17 |
Immunogen, Inc. |
Process for preparing stable drug conjugates
|
US20060246544A1
(en)
*
|
2005-03-30 |
2006-11-02 |
Neose Technologies,Inc. |
Manufacturing process for the production of peptides grown in insect cell lines
|
WO2006110277A1
(en)
*
|
2005-04-11 |
2006-10-19 |
Medarex, Inc. |
Protein purification using hcic amd ion exchange chromatography
|
TWI391399B
(zh)
|
2005-05-25 |
2013-04-01 |
Hoffmann La Roche |
測定溶離多肽之鹽濃度之方法
|
EA012801B1
(ru)
|
2005-06-14 |
2009-12-30 |
Эмджен Инк. |
Самобуферирующиеся композиции белков
|
SG10201504917PA
(en)
|
2005-07-11 |
2015-07-30 |
Macrogenics Inc |
Methods For The Treatment Of Autoimmune Disorders Using Immunosuppressive Monoclonal Antibodies With Reduced Toxicity
|
DE102005033250A1
(de)
|
2005-07-15 |
2007-01-18 |
Bioceuticals Arzneimittel Ag |
Verfahren zur Reinigung von G-CSF
|
CA2620343C
(en)
*
|
2005-08-24 |
2013-01-08 |
Immunogen, Inc. |
Process for preparing antibody maytansinoid conjugates
|
AR058568A1
(es)
|
2005-12-20 |
2008-02-13 |
Bristol Myers Squibb Co |
Metodos para producir una composicion con moleculas ctla4-ig a partir de un medio de cultivo
|
ES2439641T3
(es)
|
2005-12-20 |
2014-01-24 |
Bristol-Myers Squibb Company |
Composiciones y procedimientos de producción de una composición
|
US7531632B2
(en)
*
|
2006-02-16 |
2009-05-12 |
Gtc Biotherapeutics, Inc. |
Clarification of transgenic milk using depth filtration
|
EP1996716B1
(en)
|
2006-03-20 |
2011-05-11 |
The Regents of the University of California |
Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting
|
CN101437839A
(zh)
*
|
2006-03-20 |
2009-05-20 |
米德列斯公司 |
蛋白质纯化
|
NZ611859A
(en)
*
|
2006-04-05 |
2014-12-24 |
Abbvie Biotechnology Ltd |
Antibody purification
|
AU2013202811B2
(en)
*
|
2006-04-05 |
2015-12-17 |
Abbvie Biotechnology Ltd |
Antibody purification
|
BRPI0713426A2
(pt)
|
2006-06-14 |
2012-10-09 |
Macrogenics Inc |
métodos de tratar, diminuir a progressão, ou melhorar um ou mais sintomas de um distúrbio, e de prevenir ou retardar o inìcio de um distúrbio
|
WO2008008975A2
(en)
*
|
2006-07-14 |
2008-01-17 |
Genentech, Inc. |
Refolding of recombinant proteins
|
US7862813B2
(en)
*
|
2006-07-29 |
2011-01-04 |
Bjork Jr Robert Lamar |
Bi-specific monoclonal antibody (specific for both CD3 and CD11b) therapeutic drug
|
CN1908006B
(zh)
*
|
2006-08-07 |
2010-05-12 |
陈志南 |
一种快速纯化制备Fab片段抗体的工艺方法
|
US20100267932A1
(en)
*
|
2006-08-28 |
2010-10-21 |
Alex Eon-Duval |
Process for the purification of fc-fusion proteins
|
KR101770312B1
(ko)
|
2006-08-28 |
2017-08-22 |
아레스 트레이딩 에스.에이. |
Fc함유 단백질을 정제하는 방법
|
US8212008B2
(en)
*
|
2006-12-22 |
2012-07-03 |
Schering Corporation |
Antibodies to CD200R
|
US8058027B2
(en)
*
|
2007-01-08 |
2011-11-15 |
Millipore Corporation |
Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants
|
WO2008097926A2
(en)
*
|
2007-02-02 |
2008-08-14 |
Yale University |
Transient transfection with rna
|
US10155038B2
(en)
|
2007-02-02 |
2018-12-18 |
Yale University |
Cells prepared by transient transfection and methods of use thereof
|
US9249423B2
(en)
|
2007-02-02 |
2016-02-02 |
Yale University |
Method of de-differentiating and re-differentiating somatic cells using RNA
|
SG179488A1
(en)
|
2007-03-14 |
2012-04-27 |
Ligocyte Pharmaceuticals Inc |
Virus like particle purification
|
WO2009007993A2
(en)
*
|
2007-04-23 |
2009-01-15 |
Arvind Mallinath Lali |
A process for purification of immunoglobulins using a pseudobioaffinity adsorbent
|
LT3327026T
(lt)
|
2007-07-09 |
2019-11-11 |
Genentech Inc |
Disulfidinio ryšio redukcijos prevencija rekombinantinių polipeptidų gaminimo metu
|
WO2009032949A2
(en)
|
2007-09-04 |
2009-03-12 |
The Regents Of The University Of California |
High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection
|
EP3714906A1
(en)
*
|
2007-10-03 |
2020-09-30 |
Cornell University |
Treatment of proliferative disorders using radiolabelled antibodies to psma
|
US8883146B2
(en)
|
2007-11-30 |
2014-11-11 |
Abbvie Inc. |
Protein formulations and methods of making same
|
EP2245044A2
(en)
|
2008-01-18 |
2010-11-03 |
F. Hoffmann-La Roche AG |
Purification of non-glycosylated proteins
|
MX2010009398A
(es)
*
|
2008-02-29 |
2010-11-12 |
Biogen Idec Inc |
Proteinas de fusion de inmunoglobulinas purificadas y los metodos para su purificacion.
|
US8188242B2
(en)
*
|
2008-04-08 |
2012-05-29 |
Bio-Rad Laboratories, Inc. |
Chromatography purification of antibodies
|
CA2722466A1
(en)
|
2008-04-29 |
2009-11-05 |
Tariq Ghayur |
Dual variable domain immunoglobulins and uses thereof
|
TW201006485A
(en)
|
2008-06-03 |
2010-02-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
WO2009149189A2
(en)
|
2008-06-03 |
2009-12-10 |
Abbott Laboratories |
Dual variable domain immunoglobulins and uses thereof
|
DE102008002209A1
(de)
*
|
2008-06-04 |
2009-12-10 |
Evonik Degussa Gmbh |
Verfahren zur Aufreinigung von Erythropoietin
|
JP5674654B2
(ja)
|
2008-07-08 |
2015-02-25 |
アッヴィ・インコーポレイテッド |
プロスタグランジンe2二重可変ドメイン免疫グロブリンおよびその使用
|
US20100069616A1
(en)
*
|
2008-08-06 |
2010-03-18 |
The Regents Of The University Of California |
Engineered antibody-nanoparticle conjugates
|
LT2848625T
(lt)
|
2008-08-14 |
2019-10-10 |
Genentech, Inc. |
Priemaišų pašalinimo būdai, panaudojant reziduojančio baltymo pakeitimą jonų mainų membraninės chromatografijos pagalba
|
EP2379108B1
(en)
|
2008-12-22 |
2014-06-25 |
F. Hoffmann-La Roche AG |
Immunoglobulin purification
|
EP2398504B1
(en)
|
2009-02-17 |
2018-11-28 |
Cornell Research Foundation, Inc. |
Methods and kits for diagnosis of cancer and prediction of therapeutic value
|
TR201907573T4
(tr)
|
2009-06-03 |
2019-06-21 |
Immunogen Inc |
Konjugasyon yöntemleri̇
|
KR20190018041A
(ko)
|
2009-08-06 |
2019-02-20 |
제넨테크, 인크. |
단백질 정제 시의 바이러스 제거의 개선방법
|
IN2012DN00338A
(es)
*
|
2009-08-07 |
2015-05-22 |
Millipore Corp |
|
JP5980679B2
(ja)
|
2009-08-26 |
2016-08-31 |
コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼーション |
絹ドープを製造するプロセス
|
AU2010289527C1
(en)
|
2009-09-01 |
2014-10-30 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
EP2488658A4
(en)
|
2009-10-15 |
2013-06-19 |
Abbvie Inc |
IMMUNOGLOBULINE WITH DOUBLE VARIABLE DOMAIN AND ITS USE
|
UY32979A
(es)
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
US8304248B2
(en)
|
2009-11-16 |
2012-11-06 |
Torres Anthony R |
Protein separation via ion-exchange chromatography and associated methods, systems, and devices
|
MX354143B
(es)
|
2009-12-02 |
2018-02-14 |
Imaginab Inc |
Minicuerpos j591 y diacuerpos-cys para apuntar con especificidad de objetivo a un antígeno de membrana específico para próstata de humano (psma) y métodos para su uso.
|
WO2011084496A1
(en)
|
2009-12-16 |
2011-07-14 |
Abbott Biotherapeutics Corp. |
Anti-her2 antibodies and their uses
|
SG181496A1
(en)
|
2009-12-18 |
2012-07-30 |
Csl Ltd |
Method of purifying polypeptides
|
SG182611A1
(en)
*
|
2010-01-22 |
2012-08-30 |
Lonza Walkersville Inc |
High yield method and apparatus for volume reduction and washing of therapeutic cells using tangential flow filtration
|
CA2793959C
(en)
|
2010-03-25 |
2019-06-04 |
Oregon Health & Science University |
Cmv glycoproteins and recombinant vectors
|
EP3175844A1
(en)
|
2010-04-09 |
2017-06-07 |
Pacira Pharmaceuticals, Inc. |
Large diameter synthetic membrane vesicles
|
GB201012603D0
(en)
|
2010-07-27 |
2010-09-08 |
Ucb Pharma Sa |
Protein purification
|
BR112013002578A2
(pt)
|
2010-08-03 |
2019-05-14 |
Abbvie Inc. |
imunoglobinas de domínio variável duplo e usos das mesmas
|
TW201211252A
(en)
|
2010-08-26 |
2012-03-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
TW201302793A
(zh)
|
2010-09-03 |
2013-01-16 |
Glaxo Group Ltd |
新穎之抗原結合蛋白
|
WO2012030512A1
(en)
|
2010-09-03 |
2012-03-08 |
Percivia Llc. |
Flow-through protein purification process
|
US9422329B2
(en)
*
|
2010-11-05 |
2016-08-23 |
Hoffmann-La Roche Inc. |
Optimized method for antibody capturing by mixed mode chromatography
|
RS58367B1
(sr)
|
2011-03-29 |
2019-03-29 |
Immunogen Inc |
Priprema konjugata antitela i majtanzinoida jednostepenim postupkom
|
EP2702077A2
(en)
|
2011-04-27 |
2014-03-05 |
AbbVie Inc. |
Methods for controlling the galactosylation profile of recombinantly-expressed proteins
|
TW201307563A
(zh)
*
|
2011-05-19 |
2013-02-16 |
Shire Human Genetic Therapies |
純化乙醯肝素-n-硫酸酯酶之方法
|
CA2832109C
(en)
|
2011-06-10 |
2021-07-06 |
Oregon Health & Science University |
Cmv glycoproteins and recombinant vectors
|
US20160145589A1
(en)
|
2011-06-24 |
2016-05-26 |
Green Cross Corporation |
Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof
|
CA2838814A1
(en)
*
|
2011-08-25 |
2013-02-28 |
F.Hoffmann-La Roche Ag |
Cation and anion exchange chromatography method
|
AU2012216792A1
(en)
|
2011-09-12 |
2013-03-28 |
International Aids Vaccine Initiative |
Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
|
EA034347B1
(ru)
*
|
2011-10-26 |
2020-01-30 |
Амген Инк. |
Способ инактивации вирусов при получении антител
|
EP2586461A1
(en)
|
2011-10-27 |
2013-05-01 |
Christopher L. Parks |
Viral particles derived from an enveloped virus
|
AU2012340766B2
(en)
|
2011-11-23 |
2018-05-10 |
Medimmune, Llc |
Binding molecules specific for HER3 and uses thereof
|
KR101498771B1
(ko)
*
|
2011-12-15 |
2015-03-09 |
한화케미칼 주식회사 |
항체의 정제 방법
|
WO2013102042A2
(en)
|
2011-12-30 |
2013-07-04 |
Abbvie Inc. |
Dual specific binding proteins directed against il-13 and/or il-17
|
US9067990B2
(en)
|
2013-03-14 |
2015-06-30 |
Abbvie, Inc. |
Protein purification using displacement chromatography
|
WO2013158273A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Methods to modulate c-terminal lysine variant distribution
|
US9334319B2
(en)
|
2012-04-20 |
2016-05-10 |
Abbvie Inc. |
Low acidic species compositions
|
US9505833B2
(en)
|
2012-04-20 |
2016-11-29 |
Abbvie Inc. |
Human antibodies that bind human TNF-alpha and methods of preparing the same
|
WO2013176754A1
(en)
|
2012-05-24 |
2013-11-28 |
Abbvie Inc. |
Novel purification of antibodies using hydrophobic interaction chromatography
|
JOP20130186B1
(ar)
|
2012-06-22 |
2021-08-17 |
Takeda Vaccines Montana Inc |
تنقية الجزيئات الشبيهة بالفيروسات
|
EP2679596B1
(en)
|
2012-06-27 |
2017-04-12 |
International Aids Vaccine Initiative |
HIV-1 env glycoprotein variant
|
US9150841B2
(en)
|
2012-06-29 |
2015-10-06 |
Shire Human Genetic Therapies, Inc. |
Cells for producing recombinant iduronate-2-sulfatase
|
KR101380740B1
(ko)
|
2012-06-29 |
2014-04-11 |
쉐어 휴먼 제네텍 세러피스, 인코포레이티드 |
이듀로네이트-2-설파타제의 정제
|
EP2682168A1
(en)
|
2012-07-02 |
2014-01-08 |
Millipore Corporation |
Purification of biological molecules
|
US20140031527A1
(en)
*
|
2012-07-27 |
2014-01-30 |
Csl Limited |
Method for polishing albumin
|
PT2888283T
(pt)
|
2012-08-24 |
2018-11-16 |
Univ California |
Anticorpos e vacinas para serem utilizados no tratamento de cancros que expressam ror1 e inibição de metástases
|
US9206390B2
(en)
|
2012-09-02 |
2015-12-08 |
Abbvie, Inc. |
Methods to control protein heterogeneity
|
US9512214B2
(en)
|
2012-09-02 |
2016-12-06 |
Abbvie, Inc. |
Methods to control protein heterogeneity
|
WO2014052713A2
(en)
*
|
2012-09-27 |
2014-04-03 |
Massachusetts Institute Of Technology |
Her2-and vegf-a-binding proteins with enhanced stability
|
RU2018122734A
(ru)
|
2012-10-04 |
2018-07-24 |
Иммуноджен, Инк. |
Использование пвдф-мембраны для очистки конъюгатов клеточно-связывающий агент-цитотоксический агент
|
RU2017137740A
(ru)
|
2012-11-01 |
2019-02-11 |
Эббви Инк. |
Анти-vegf/dll4-иммуноглобулины с двойными вариабельными доменами и их применения
|
US10188965B2
(en)
|
2012-12-05 |
2019-01-29 |
Csl Behring Gmbh |
Hydrophobic charge induction chromatographic depletion of a protein from a solution
|
US20140154233A1
(en)
*
|
2012-12-05 |
2014-06-05 |
Csl Limited |
Method of purifying therapeutic proteins
|
SG10201709131UA
(en)
|
2013-03-08 |
2017-12-28 |
Genzyme Corp |
Continuous purification of therapeutic proteins
|
US10023608B1
(en)
|
2013-03-13 |
2018-07-17 |
Amgen Inc. |
Protein purification methods to remove impurities
|
WO2014159579A1
(en)
|
2013-03-14 |
2014-10-02 |
Abbvie Inc. |
MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
|
WO2014151878A2
(en)
|
2013-03-14 |
2014-09-25 |
Abbvie Inc. |
Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
|
US9017687B1
(en)
|
2013-10-18 |
2015-04-28 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same using displacement chromatography
|
EP2970459A2
(en)
|
2013-03-15 |
2016-01-20 |
AbbVie Inc. |
Dual specific binding proteins directed against il-1beta and il-17
|
US10611826B2
(en)
|
2013-07-05 |
2020-04-07 |
Laboratoire Français Du Fractionnement Et Des Biotechnologies |
Affinity chromatography matrix
|
CN105473610A
(zh)
|
2013-08-21 |
2016-04-06 |
卡迪拉保健有限公司 |
用于pth的纯化方法
|
US20150065381A1
(en)
|
2013-09-05 |
2015-03-05 |
International Aids Vaccine Initiative |
Methods of identifying novel hiv-1 immunogens
|
NZ756750A
(en)
|
2013-09-13 |
2022-05-27 |
Genentech Inc |
Methods and compositions comprising purified recombinant polypeptides
|
JP6546178B2
(ja)
|
2013-09-13 |
2019-07-17 |
ジェネンテック, インコーポレイテッド |
細胞株中の宿主細胞タンパク質及び組換えポリペプチド産物を検出及び定量化するための組成物並びに方法
|
US11305012B2
(en)
|
2013-09-24 |
2022-04-19 |
Medimmune, Llc |
Binding molecules specific for HER3 and uses thereof
|
EP3052640A2
(en)
|
2013-10-04 |
2016-08-10 |
AbbVie Inc. |
Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
|
EP2873423B1
(en)
|
2013-10-07 |
2017-05-31 |
International Aids Vaccine Initiative |
Soluble hiv-1 envelope glycoprotein trimers
|
US8946395B1
(en)
|
2013-10-18 |
2015-02-03 |
Abbvie Inc. |
Purification of proteins using hydrophobic interaction chromatography
|
US9085618B2
(en)
|
2013-10-18 |
2015-07-21 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same
|
US9181337B2
(en)
|
2013-10-18 |
2015-11-10 |
Abbvie, Inc. |
Modulated lysine variant species compositions and methods for producing and using the same
|
US20150139988A1
(en)
|
2013-11-15 |
2015-05-21 |
Abbvie, Inc. |
Glycoengineered binding protein compositions
|
TWI709570B
(zh)
|
2014-01-17 |
2020-11-11 |
美商健臻公司 |
無菌層析法及製法
|
TWI709569B
(zh)
|
2014-01-17 |
2020-11-11 |
美商健臻公司 |
無菌層析樹脂及其用於製造方法的用途
|
US9821274B1
(en)
*
|
2014-02-09 |
2017-11-21 |
Spf Innovations Llc |
Hybrid diafiltration system and methods
|
JP2017507938A
(ja)
*
|
2014-02-19 |
2017-03-23 |
エイジェンシー・フォー・サイエンス,テクノロジー・アンド・リサーチ |
分別法
|
SG11201607341SA
(en)
*
|
2014-03-04 |
2016-10-28 |
Merck Patent Gmbh |
Robust antibody purification
|
KR101921552B1
(ko)
|
2014-03-10 |
2018-11-23 |
리히터 게데온 닐트. |
사전 세정 단계를 이용하는 면역글로불린 정제
|
US10745490B2
(en)
|
2014-04-11 |
2020-08-18 |
Celldex Therapeutics, Inc. |
Anti-ErbB antibodies and methods of use thereof
|
JP6071018B2
(ja)
|
2014-10-31 |
2017-02-01 |
Jcrファーマ株式会社 |
組換えヒトDNaseIの製造方法
|
WO2016094881A2
(en)
|
2014-12-11 |
2016-06-16 |
Abbvie Inc. |
Lrp-8 binding proteins
|
WO2016144658A1
(en)
*
|
2015-03-10 |
2016-09-15 |
Merck Sharp & Dohme Corp. |
Process for preparing recombinant insulin using microfiltration
|
CN104730178B
(zh)
*
|
2015-03-13 |
2016-10-19 |
安徽皖仪科技股份有限公司 |
全自动高压供水管道在线原位离子色谱检测取、进样装置
|
US10174292B2
(en)
|
2015-03-20 |
2019-01-08 |
International Aids Vaccine Initiative |
Soluble HIV-1 envelope glycoprotein trimers
|
US9931394B2
(en)
|
2015-03-23 |
2018-04-03 |
International Aids Vaccine Initiative |
Soluble HIV-1 envelope glycoprotein trimers
|
TW201710286A
(zh)
|
2015-06-15 |
2017-03-16 |
艾伯維有限公司 |
抗vegf、pdgf及/或其受體之結合蛋白
|
KR20180050321A
(ko)
|
2015-08-07 |
2018-05-14 |
이미지냅 인코포레이티드 |
분자를 표적화하기 위한 항원 결합 구조체
|
US9925258B2
(en)
|
2015-10-02 |
2018-03-27 |
International Aids Vaccine Initiative |
Replication-competent VSV-HIV Env vaccines
|
CN105399810A
(zh)
*
|
2015-11-21 |
2016-03-16 |
青岛康原药业有限公司 |
一种人表皮生长因子的制备方法及增加人表皮生长因子复溶性的药物组合物
|
CN109996544A
(zh)
|
2016-06-27 |
2019-07-09 |
加利福尼亚大学董事会 |
癌症治疗组合
|
MX2019001859A
(es)
|
2016-08-16 |
2019-08-29 |
Genzyme Corp |
Metodos de procesamiento de un fluido que incluye una proteina terapeutica recombinante y uso de los mismos.
|
EP3528787A4
(en)
|
2016-10-21 |
2020-05-06 |
Amgen Inc. |
PHARMACEUTICAL FORMULATIONS AND PROCESSES FOR THEIR PREPARATION
|
WO2018147960A1
(en)
|
2017-02-08 |
2018-08-16 |
Imaginab, Inc. |
Extension sequences for diabodies
|
CN110128538B
(zh)
*
|
2018-02-09 |
2022-08-26 |
鲁南制药集团股份有限公司 |
一种纯化抗cd20人鼠嵌合单克隆抗体的方法
|
BR112021003420A2
(pt)
|
2018-08-31 |
2021-05-18 |
Genzyme Corporation |
resina cromatográfica estéril e uso da mesma em processos de manufatura
|
US20220041650A1
(en)
*
|
2018-12-03 |
2022-02-10 |
Duke University |
Purification method for recombinant proteins and nanoparticles
|
KR20200080748A
(ko)
*
|
2018-12-27 |
2020-07-07 |
주식회사 폴루스 |
음이온 교환 크로마토그래피를 이용한 인슐린 전구체의 정제방법
|
MX2021010891A
(es)
*
|
2019-03-11 |
2021-12-10 |
Genzyme Corp |
Filtracion tangencial de virus.
|
KR20220034169A
(ko)
*
|
2019-07-10 |
2022-03-17 |
리제너론 파아마슈티컬스, 인크. |
감소된 수준의 숙주 세포 단백질을 포함하는 방법 및 조성물
|
EP3844169A4
(en)
*
|
2019-08-16 |
2021-12-15 |
Applied Molecular Transport Inc. |
COMPOSITIONS, FORMULATIONS AND PRODUCTION AND PURIFICATION OF INTERLEUKINS
|
CN114230641B
(zh)
*
|
2021-12-29 |
2024-03-26 |
内蒙古必威安泰生物科技有限公司 |
一种去除口蹄疫抗原液中内毒素的方法
|